Insiders who reported open-market trades in the last 12 months at the companies Myriam Curet files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Myriam Curet is a corporate insider, tracked as Director of Mobia Medical, Inc. (MOBI). InsiderAlpha holds 19 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Myriam Curet submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Myriam Curet been buying or selling stock?
Recorded transactions: 2 open-market purchases ($804) and 23 open-market sales ($19.87M) across all tracked filings.
Myriam Curet is Director of Mobia Medical, Inc. (MOBI). 19 SEC Form 4 filings on record going back to 2024, most recently on 3 August 2026. Most recent open-market trade: sold $52K of ISRG on 11 March 2026. Lifetime open-market purchases: $804. Lifetime open-market sales: $19.87M.
Recent transactions
20
The latest 20 SEC Form 4 transactions reported by Myriam Curet.
InsiderAlpha's records for Myriam Curet go back to 2024: 19 primary Form 4 filings, an average of 6.3 per year. The typical open-market purchase is $402 (2 buys totaling $804). The largest single buy on record is $655 of INSP in 2025. Sales side: 23 recorded sales totaling $19.87M, so the filing history runs sell-heavy by dollar value. 61 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
